Get the Stockscreener App
0.3586
19.53%
0.0586
After Hours:
.36
0.0014
+0.39%
Anebulo Pharmaceuticals Inc stock is traded at $0.3586, with a volume of 100.
It is up +19.53% in the last 24 hours and up +19.53% over the past month.
ANEBULO PHARMAC INC
See More
Previous Close:
$0.30
Open:
$0.3586
24h Volume:
100
Relative Volume:
0.03
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
$-7.98M
P/E Ratio:
-1.8465
EPS:
-0.1942
Net Cash Flow:
$-5.84M
1W Performance:
+8.67%
1M Performance:
+19.53%
6M Performance:
-80.88%
1Y Performance:
-55.39%
1-Day Range:
$0.3586
$0.3586
1-Week Range:
$0.30
$0.3586
52-Week Range:
$0.0004
$1.12
Anebulo Pharmaceuticals Inc Stock (ANEB) Company Profile
Name
Anebulo Pharmaceuticals Inc
Sector
Industry
Phone
-
Address
-
Compare ANEB vs VRTX, REGN, ARGX, MRNA, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals Inc
|
0.3586 | 0 | 0 | -7.98M | -5.84M | -0.1942 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Anebulo Pharmaceuticals Inc Stock (ANEB) Latest News
Anebulo Pharmaceuticals Inc Revenue Breakdown – OTC:ANEB - TradingView
Anebulo Pharmaceuticals, Inc. Revenue Breakdown – LS:A3CM1D - TradingView
Stabilis Solutions And 2 Other High-Quality Penny Stocks For Savvy Investors - simplywall.st
Anebulo Pharmaceuticals (ANEB) Proxy Filing Summary - Quartr
Enterprise value to EBITDA forward of Anebulo Pharmaceuticals Inc – OTC:ANEB - TradingView
Total assets of Anebulo Pharmaceuticals from 2021 to 2025 - Statista
Enterprise value to revenue forward of Anebulo Pharmaceuticals Inc – OTC:ANEB - TradingView
Enterprise value to revenue forward of Anebulo Pharmaceuticals, Inc. – LSX:A3CM1D - TradingView
Price to sales forward of Anebulo Pharmaceuticals Inc – OTC:ANEB - TradingView
Anebulo Pharmaceuticals, Inc. Financial Disclosures & Filings - TradingView
Anebulo Pharmaceuticals, Inc. Actuals & Estimates (OTC:ANEB) - TradingView
Anebulo Pharmaceuticals Inc (ANEB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Anebulo Pharmaceuticals Inc (ANEB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Anebulo Pharmaceuticals Inc (ANEB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Anebulo Pharmaceuticals Inc (ANEB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Anebulo Pharmaceuticals Inc (ANEB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Anebulo Pharmaceuticals Inc (ANEB) Institutional Confidence - TradingKey
Anebulo Pharmaceuticals Inc (ANEB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Anebulo Pharmaceuticals Inc - TradingKey
Anebulo Pharmaceuticals Inc (ANEB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
Anebulo’s Selonabant Phase 1 Completion: What Investors Should Watch Next - TipRanks
ANEB Price Today: Anebulo Pharmaceuticals, Inc. Stock Price, Quote & Chart | MEXC - mexc.co
Risk Recap: Why is Anebulo Pharmaceuticals Inc stock going downJobs Report & Real-Time Buy Signal Alerts - baoquankhu1.vn
Layoff Watch: Is Anebulo Pharmaceuticals Inc gaining market shareTrade Risk Report & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Is Anebulo Pharmaceuticals Inc gaining market share2026 Earnings & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Anebulo Pharmaceuticals, Inc. (ANEB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Pullback Watch: Whats the beta of Anebulo Pharmaceuticals Inc stockWeekly Risk Report & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Anebulo Pharmaceuticals, Inc. (214.F) stock price, news, quote and history - Yahoo Finance UK
Aug PreEarnings: What are Anebulo Pharmaceuticals Incs earnings expectationsQuarterly Trade Report & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Anebulo Pharmaceuticals Inc (ANEB) Dividends - The Globe and Mail
Why Is Anebulo Pharmaceuticals, Inc. (ANEB) Stock Down Today? - Meyka
Aug Sectors: Will Anebulo Pharmaceuticals Inc outperform the market in YEAR2025 Big Picture & Weekly Market Pulse Updates - baoquankhu1.vn
Anebulo Pharmaceuticals launches self-tender offer to go private - MSN
EBITDA margin % of Anebulo Pharmaceuticals Inc – OTC:ANEB - TradingView
Return on assets % of Anebulo Pharmaceuticals Inc – OTC:ANEB - TradingView
ANEB SEC FilingsAnebulo Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Equity in earnings of Anebulo Pharmaceuticals Inc – OTC:ANEB - TradingView
Update Recap: What are Anebulo Pharmaceuticals Incs earnings expectationsEarnings Miss & High Conviction Buy Zone Picks - baoquankhu1.vn
Basic earnings per share (basic EPS) of Anebulo Pharmaceuticals Inc – OTC:ANEB - TradingView
Anebulo Pharmaceuticals, Inc.(NasdaqCM: ANEB) dropped from S&P TMI Index - marketscreener.com
Anebulo Pharmaceuticals | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)moomoo - Moomoo
Anebulo Pharmaceuticals, Inc.(OTCPK: ANEB) dropped from NASDAQ Composite Index - marketscreener.com
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Up 188.7% in February - Defense World
12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com
Anebulo Pharmaceuticals | 25: Notification of the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)moomoo - Moomoo
Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn - marketscreener.com
Anebulo Pharmaceuticals Announces Voluntary Nasdaq Delisting Plan - The Globe and Mail
Anebulo Pharmaceuticals stock plunges after announcing Nasdaq delisting plans By Investing.com - Investing.com Nigeria
Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC - Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Anebulo Pharmaceuticals Inc Stock (ANEB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.86%
0.31%
Cap:
|
Volume (24h):